SCHEMBL26099994

SCHEMBL26099994

CCOC(=O)c1c(C)nn(C2CC2)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.43
GRK6 P43250 1/20 0.41
PLAT P00750 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
PDE4B Q07343 1/20 0.39
MAPK1 P28482 1/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
PDE7A Q13946 1/20 0.38
ALDH1A1 P00352 3/20 0.37
GAA P10253 3/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22286136 0.84 MAPK1 (0.50) PDE4DGRK6PLATPDE4BMAPK1
SCHEMBL6070905 0.79 PDE4D (0.47) PDE4DPDE4BMAPK1SMN1; SMN2PDE7A
SCHEMBL20551525 0.78 MAPK1 (0.48) PDE4DGRK6PLATMAPK1SMN1; SMN2
SCHEMBL4519120 0.78 MAPK1 (0.48) PDE4DGRK6MAPK1SMN1; SMN2PDE7A
SCHEMBL20551562 0.77 MAPK1 (0.47) PDE4DGRK6MAPK1SMN1; SMN2PDE7A
SCHEMBL26104148 0.76 PDE4D (0.48) PDE4DCA12CA1CA2CA7
SCHEMBL20551710 0.75 MAPK1 (0.45) PDE4DGRK6PLATPDE4BMAPK1
SCHEMBL16244423 0.75 PDE7A (0.39) PDE4DGRK6MAPK1SMN1; SMN2PDE7A
SCHEMBL31637698 0.75 GRK6 (0.40) PDE4DGRK6PLATCA12CA1
SCHEMBL28443313 0.75 ALDH1A1 (0.42) PDE4DGRK6MAPK1SMN1; SMN2PDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132127-A1 NOVEL SPIRO COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-05-14 US disclosed
CN-118176179-A Novel spiro compounds 田边三菱制药株式会社 2024-06-11 CN disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132127-A1 NOVEL SPIRO COMPOUND TRHR, NR3C2, THRB PDE4D 1655/4885GRK6 367/4885PLAT 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.